Xenetic Biosciences (XBIO) Institutional Ownership $3.20 -0.04 (-1.20%) As of 08/1/2025 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Xenetic Biosciences (NASDAQ:XBIO)CurrentInstitutional OwnershipPercentage15.12%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$100.60KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$39.90K Get XBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Xenetic Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data XBIO Institutional Buying and Selling by Quarter Xenetic Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/23/2025 Sachetta LLC15,259$60K0.0%+43.1%0.991% 2/13/2025Renaissance Technologies LLC25,550$102K0.0%+61.2%1.659% 2/6/2025 LGT Group Foundation11,000$41K0.0%N/A0.714% 1/21/2025 Sachetta LLC7,371$29K0.0%-57.6%0.478% 2/8/2022Steward Partners Investment Advisory LLC19,000$25K0.0%N/A0.142% 11/12/2021Renaissance Technologies LLC418,890$859K0.0%+196.6%4.317% 8/13/2021Renaissance Technologies LLC141,221$288K0.0%-43.8%1.615% 8/13/2021Geode Capital Management LLC50,510$103K0.0%+61.6%0.577% 8/10/2021 JTC Employer Solutions Trusteee Ltd26,991$55K0.0%N/A0.309% 5/21/2021Citadel Advisors LLC92,002$201K0.0%N/A1.052% 5/19/2021Virtu Financial LLC37,196$81K0.0%+89.8%0.425% 5/18/2021Citadel Advisors LLC92,002$201K0.0%N/A1.052% 5/12/2021Geode Capital Management LLC31,261$68K0.0%+137.1%0.357% (Data available from 1/1/2016 forward) XBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XBIO shares? During the previous two years, the following institutional investors and hedge funds held shares of Xenetic Biosciences shares: Renaissance Technologies LLC ($102K), and Sachetta LLC ($60K), LGT Group Foundation ($41K).Learn more on Xenetic Biosciences' institutional investors. What percentage of Xenetic Biosciences' stock is owned by institutional investors? 15.12% of Xenetic Biosciences' stock is owned by institutional investors. Learn more on XBIO's institutional investor holdings. Which institutional investors have been buying Xenetic Biosciences' stock? The following institutional investors have purchased Xenetic Biosciences' stock in the last 24 months: LGT Group Foundation ($11K), Renaissance Technologies LLC ($9.70K), and Sachetta LLC ($4.59K). How much institutional buying is happening at Xenetic Biosciences? Institutional investors have bought a total of 25,293 shares in the last 24 months. This purchase volume represents approximately $100.60K in transactions. Which of Xenetic Biosciences' major shareholders have been selling company stock? The following institutional investors have sold Xenetic Biosciences stock in the last 24 months: Sachetta LLC ($10K). How much institutional selling is happening at Xenetic Biosciences? Institutional investors have sold a total of 10,000 shares in the last 24 months. This volume of shares sold represents approximately $39.90K in transactions. Related Companies VYNE Institutional Ownership ELEV Institutional Ownership CVKD Institutional Ownership MBRX Institutional Ownership CYCC Institutional Ownership CMMB Institutional Ownership RLMD Institutional Ownership BCAB Institutional Ownership ATNF Institutional Ownership PASG Institutional Ownership This page (NASDAQ:XBIO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.